Plaintiff's Xarelto victory is short-lived as judge overturns $28M verdict against Bayer and J&J
admin 10th January 2018 Uncategorised 0The first verdict to go against Bayer and Johnson & Johnson over Xarelto’s bleeding risks didn’t stand up to court scrutiny. A U.S. judge overturned the $28 million award on grounds it was an unreasonable result.
More: Plaintiff's Xarelto victory is short-lived as judge overturns M verdict against Bayer and J&J
Source: fierce